Search Results - "Bodger, K."

Refine Results
  1. 1

    Cost‐effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient‐level cost data by BODGER, K., KIKUCHI, T., HUGHES, D.

    Published in Alimentary pharmacology & therapeutics (01-08-2009)
    “…Summary Background  Anti‐TNF‐alpha agents for Crohn's disease (CD) have good clinical efficacy but high acquisition cost compared to rival drugs. Aim  To…”
    Get full text
    Journal Article
  2. 2

    Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study by Bassi, A, Dodd, S, Williamson, P, Bodger, K

    Published in Gut (01-10-2004)
    “…Background and aims: The potentially high costs of care associated with inflammatory bowel disease (IBD) are recognised but we have little knowledge of the…”
    Get full text
    Journal Article
  3. 3

    Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study by Geraghty, J., Shawihdi, M., Devonport, E., Sarkar, S., Pearson, M. G., Bodger, K.

    Published in Colorectal disease (01-02-2018)
    “…Aim We wanted to find out if roll‐out of the bowel cancer screening programme (BCSP) across England was associated with a reduced risk of emergency hospital…”
    Get full text
    Journal Article
  4. 4

    Predictive value of alarm features in a rapid access upper gastrointestinal cancer service by Kapoor, N, Bassi, A, Sturgess, R, Bodger, K

    Published in Gut (01-01-2005)
    “…Aims: (i) To determine the value of individual alarm features for predicting cancer in subjects referred to a rapid access upper gastrointestinal cancer…”
    Get full text
    Journal Article
  5. 5

    Management of large bowel obstruction with self-expanding metal stents. A multicentre retrospective study of factors determining outcome by Geraghty, J., Sarkar, S., Cox, T., Lal, S., Willert, R., Ramesh, J., Bodger, K., Carlson, G. L.

    Published in Colorectal disease (01-06-2014)
    “…Aim UK cancer guidelines recommend patients with colonic obstruction due to suspected malignancy be considered for stenting with a self‐expanding metal stent…”
    Get full text
    Journal Article
  6. 6

    The cost‐utility of high dose oral mesalazine for moderately active ulcerative colitis by BUCKLAND, A., BODGER, K.

    Published in Alimentary pharmacology & therapeutics (01-12-2008)
    “…Summary Background  Mesalazine (mesalamine) is standard first line treatment for moderately active ulcerative colitis (UC). Recently, doubling the mesalazine…”
    Get full text
    Journal Article
  7. 7

    Inequalities in outcomes of acute kidney injury in England by ABRAHAM, K. A, THOMPSON, E. B, BODGER, K, PEARSON, M

    Published in QJM : An International Journal of Medicine (01-08-2012)
    “…Renal replacement is managed by renal specialists and is well documented in national registries. In contrast, nation-wide data on acute kidney injury (AKI) are…”
    Get full text
    Journal Article
  8. 8

    Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm by Geraghty, J, Butler, P, Seaman, H, Snowball, J, Sarkar, S, Blanks, R, Halloran, S, Bodger, K, Rees, C J

    Published in British journal of cancer (25-11-2014)
    “…Background: Colorectal neoplasia causes bleeding, enabling detection using Faecal Occult Blood tests (FOBt). The National Health Service (NHS) Bowel Cancer…”
    Get full text
    Journal Article
  9. 9

    Commissioning for COPD care: a new, recordable metric that supports the patient interest by Walker, Paul Phillip, Thompson, E., Hill, S.L., Holton, K., Bodger, K., Pearson, M.G.

    Published in Journal of public health (Oxford, England) (01-06-2016)
    “…Healthcare metrics have been used to drive improvement in outcome and delivery in UK hospital stroke and cardiac care. This model is attractive for chronic…”
    Get full text
    Journal Article
  10. 10

    Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients by Bodger, K, Halfvarson, J, Dodson, A R, Campbell, F, Wilson, S, Lee, R, Lindberg, E, Järnerot, G, Tysk, C, Rhodes, J M

    Published in Gut (01-07-2006)
    “…Background and aims: Previous chromatographic analysis of colonic mucins from monozygotic twins with inflammatory bowel disease (IBD) suggested a genetic mucin…”
    Get full text
    Journal Article
  11. 11

    Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope by Bodger, K, Campbell, F, Rhodes, J M

    Published in Journal of clinical pathology (01-09-2003)
    “…Premalignant Barrett's oesophagus (BO) and gastric intestinal metaplasia (IM) show phenotypic variability. Incompletely differentiated sulfomucin rich gastric…”
    Get full text
    Journal Article
  12. 12

    Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection by Bodger, K, Ahmed, S, Pazmany, L, Pritchard, D M, Micheal, A, Khan, A L, Dimaline, R, Dockray, G J, Varro, A

    Published in Journal of clinical pathology (01-01-2008)
    “…Matrix metalloproteinases (MMPs) have roles in inflammation and other processes relevant to the architectural disturbances seen in the gastric mucosa in…”
    Get more information
    Journal Article
  13. 13

    Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion by Bodger, K, Wyatt, J I, Heatley, R V

    Published in Gut (01-06-1997)
    “…BACKGROUND: Interleukin-10 (IL-10) is an 18 kDa peptide with a range of anti-inflammatory and immunosuppressive properties. AIM: To determine whether this…”
    Get full text
    Journal Article
  14. 14

    Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion by Bodger, K, Bromelow, K, Wyatt, J I, Heatley, R V

    Published in Journal of clinical pathology (01-04-2001)
    “…Background/Aims—Interleukin 10 (IL-10) is a counterinflammatory peptide implicated in the downregulation of human intestinal immune responses. Enhanced…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Dissatisfaction with consent for diagnostic gastrointestinal endoscopy by Bassi, A, Brown, E, Kapoor, N, Bodger, K

    Published in Digestive diseases (Basel) (01-01-2002)
    “…Little is known about patients' perspectives on the amount of information they receive prior to diagnostic gastrointestinal endoscopies. Our unit's policy for…”
    Get more information
    Journal Article
  17. 17

    Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners by Bodger, K, Daly, M J, Heatley, R V

    Published in Alimentary pharmacology & therapeutics (01-12-1996)
    “…To define prescribing patterns for symptomatic dyspeptic patients in a cross-section of general practitioners in Leeds, United Kingdom. Nine general…”
    Get more information
    Journal Article
  18. 18

    Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia Guidelines (1996) by BODGER, K, EASTWOOD, P. G, MANNING, S. I, DALY, M. J, HEATLEY, R. V

    Published in Alimentary pharmacology & therapeutics (01-04-2000)
    “…Aim: To define the characteristics of patients consulting with active dyspeptic symptoms in urban general practice, and to consider the implications of…”
    Get full text
    Journal Article
  19. 19

    Serologic Screening before Endoscopy: The Value of Helicobacter pylori Serology, Serum Recognition of the CagA and VacA Proteins, and Serum Pepsinogen I by BODGER, K, WYATT, J. I, HEATLEY, R. V

    “…Background: We wanted to assess the diagnostic value of pre-endoscopy screening by Helicobacter pylori serology, serum recognition of the CagA and VacA…”
    Get full text
    Journal Article
  20. 20